Team Advises Global Top 25 Pharmaceutical and Biotech Company

  • Life Sciences

Team is advising Global Top 25 Pharmaceutical and Biotech Company on various legal aspects of medicines pricing, procurement and reimbursement reform, introduction of the National Essential Medicines List and expected transformation in state funding of rare diseases treatment.

In the course of Healthcare Reform implementation, Ukraine is undergoing significant transformation of the system of state funding of medicines, medical devices and medical services. Introduction of the National Essential Medicines List, development of procurement and reimbursement procedures concern all global innovative companies, especially those working in specialized and orphan medicines areas. Adaptation to the constantly changing regulatory environment is crucial for the Ukrainian market players these days.

Team
This site uses cookies. An explanation of their purpose can be found within Terms of Use